Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Feb 15;89(4):1169–1173. doi: 10.1073/pnas.89.4.1169

Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells.

R Maneckjee 1, J D Minna 1
PMCID: PMC48410  PMID: 1311082

Abstract

Methadone was found to significantly inhibit the in vitro and in vivo growth of human lung cancer cells. The in vitro growth inhibition (occurring at 1-100 nM methadone) was associated with changes in cell morphology and viability detectable within 1 hr and was irreversible after a 24-hr exposure to the drug. These effects of methadone could be reversed in the first 6 hr by naltrexone, actinomycin D, and cycloheximide, suggesting involvement of opioid-like receptors and the requirement for de novo mRNA and protein synthesis. The inhibitory effects of methadone on the growth of lung cancer cells also could be achieved by the less addictive (+) isomer of methadone. Characterization of the methadone binding to lung cancer cell membranes revealed high-affinity (nM), saturable binding sites for (+/-)-[3H]methadone, which cross-reacted with ligands for kappa, phencyclidine, sigma, but not mu, and delta opioid receptors, and the binding characteristics appeared to be different from methadone sites present in rat brain. Methadone decreases cAMP levels in lung cancer cells, but the receptors are not coupled to a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. We conclude that the lung cancer growth inhibitory effects of methadone are significant, occur at low concentrations, and are mediated by a nonconventional type of opioid binding site distinct from methadone receptors found in the brain.

Full text

PDF
1169

Images in this article

1170Image
on p.1170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aylsworth C. F., Hodson C. A., Meites J. Opiate antagonists can inhibit mammary tumor growth in rats. Proc Soc Exp Biol Med. 1979 May;161(1):18–20. doi: 10.3181/00379727-161-40479. [DOI] [PubMed] [Google Scholar]
  2. Brower M., Carney D. N., Oie H. K., Gazdar A. F., Minna J. D. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986 Feb;46(2):798–806. [PubMed] [Google Scholar]
  3. Carney D. N., Cuttitta F., Moody T. W., Minna J. D. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res. 1987 Feb 1;47(3):821–825. [PubMed] [Google Scholar]
  4. Carney D. N., Gazdar A. F., Bepler G., Guccion J. G., Marangos P. J., Moody T. W., Zweig M. H., Minna J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985 Jun;45(6):2913–2923. [PubMed] [Google Scholar]
  5. Choi D. W., Viseskul V. Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons. Eur J Pharmacol. 1988 Oct 11;155(1-2):27–35. doi: 10.1016/0014-2999(88)90399-8. [DOI] [PubMed] [Google Scholar]
  6. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986 May 22;89(2):271–277. doi: 10.1016/0022-1759(86)90368-6. [DOI] [PubMed] [Google Scholar]
  7. Dole V. P. Implications of methadone maintenance for theories of narcotic addiction. JAMA. 1988 Nov 25;260(20):3025–3029. [PubMed] [Google Scholar]
  8. Fraser A. D. Clinical toxicology of drugs used in the treatment of opiate dependency. Clin Lab Med. 1990 Jun;10(2):375–386. [PubMed] [Google Scholar]
  9. Gazdar A. F., Oie H. K. Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986 Nov;46(11):6011–6012. [PubMed] [Google Scholar]
  10. Inturrisi C. E., Portenoy R. K., Max M. B., Colburn W. A., Foley K. M. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther. 1990 May;47(5):565–577. doi: 10.1038/clpt.1990.77. [DOI] [PubMed] [Google Scholar]
  11. Maneckjee R., Minna J. D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci U S A. 1990 May;87(9):3294–3298. doi: 10.1073/pnas.87.9.3294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  13. Murgo A. J. Modulation of murine melanoma growth by naloxone. Cancer Lett. 1989 Feb;44(2):137–142. doi: 10.1016/0304-3835(89)90008-6. [DOI] [PubMed] [Google Scholar]
  14. Pert C. B., Snyder S. H. Opiate receptor: demonstration in nervous tissue. Science. 1973 Mar 9;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011. [DOI] [PubMed] [Google Scholar]
  15. Reynolds I. J., Murphy S. N., Miller R. J. 3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7744–7748. doi: 10.1073/pnas.84.21.7744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Roth K. A., Barchas J. D. Small cell carcinoma cell lines contain opioid peptides and receptors. Cancer. 1986 Feb 15;57(4):769–773. doi: 10.1002/1097-0142(19860215)57:4<769::aid-cncr2820570415>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  17. Scholar E. M., Violi L., Hexum T. D. The antimetastatic activity of enkephalin-like peptides. Cancer Lett. 1987 May;35(2):133–138. doi: 10.1016/0304-3835(87)90036-x. [DOI] [PubMed] [Google Scholar]
  18. Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982 Aug;94(2):325–334. doi: 10.1083/jcb.94.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zagon I. S., McLaughlin P. J., Goodman S. R., Rhodes R. E. Opioid receptors and endogenous opioids in diverse human and animal cancers. J Natl Cancer Inst. 1987 Nov;79(5):1059–1065. [PubMed] [Google Scholar]
  20. Zagon I. S., McLaughlin P. J. Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma. Brain Res Bull. 1981 Jul;7(1):25–32. doi: 10.1016/0361-9230(81)90094-0. [DOI] [PubMed] [Google Scholar]
  21. Zagon I. S., McLaughlin P. J. Naltrexone modulates tumor response in mice with neuroblastoma. Science. 1983 Aug 12;221(4611):671–673. doi: 10.1126/science.6867737. [DOI] [PubMed] [Google Scholar]
  22. Zukin S. R., Fitz-Syage M. L., Nichtenhauser R., Zukin R. S. Specific binding of [3H]phencyclidine in rat central nervous tissue: further characterization and technical considerations. Brain Res. 1983 Jan 10;258(2):277–284. doi: 10.1016/0006-8993(83)91151-4. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES